Codon Devices closes on $13M first funding round

Codon Devices, a Cambridge startup focusing on applications of synthetic biology, has closed on an A Round of financing of $13 million. The company, launched last year, represents a gathering of blue-chip investors and gold-standard scientists.

Flagship Ventures led the round, with Alloy Ventures, Kleiner Perkins, and Vinod Khosla co-investing. Khosla is the founding CEO of Sun Microsystems.

Founding scientists include George Church of Harvard, Drew Endy of MIT, Joseph Jacobson of MIT and Jay Keasling of the University of California, Berkeley.

Codon Devices has internally developed and licensed-in intellectual property related to the efficient synthesis of DNA code as well as designs and processes involving biological systems.

The company's early commercial focus is on providing engineered devices for molecular biology research, improved cell engineering for the production of high-value chemicals, and engineered biotherapeutics.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.